Literature DB >> 27427547

Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.

K Grisar1, M Schol2, J Schoenaers3, T Dormaar3, R Coropciuc3, V Vander Poorten4, C Politis3.   

Abstract

The purpose of this study was to compare medication-related osteonecrosis of the jaw (MRONJ) with osteoradionecrosis (ORN). Group 1 comprised 74 MRONJ patients (93 lesions) and group 2 comprised 59 ORN patients (69 lesions). Patient characteristics, clinical presentation of the lesions, the presence of complications, and the relationship with previous dental extractions were analyzed for both groups. Significant differences were found between the groups with regard to the characteristics of the patient populations, extraction as the precipitating event, the type of initial complaint, the prevalence of pain, and the location of the lesions. In the ORN group, significantly more patients complained of pain (P=0.0108) compared with the MRONJ group. Furthermore, significantly more pathological fractures (P<0.0001) and skin fistulae (P<0.0001) occurred in the ORN group. The treatment was more often conservative in the MRONJ group than in the ORN group (61.3% vs. 36.2%). Despite similarities in terms of imaging, risk factors, prevention, and treatment, MRONJ and ORN are two distinct pathological entities, as highlighted by the differences in patient characteristics, the initial clinical presentation, course of the disease, and outcome.
Copyright © 2016 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MRONJ; ORN; osteonecrosis; risk factors; treatment

Mesh:

Substances:

Year:  2016        PMID: 27427547     DOI: 10.1016/j.ijom.2016.06.016

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  7 in total

1.  Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report.

Authors:  Marcelo Vieira da Costa Almeida; Antonio C Moura; Lúcia Santos; Luciana Gominho; Ully Dias Nascimento Távora Cavalcanti; Kaline Romeiro
Journal:  J Lasers Med Sci       Date:  2021-03-08

2.  Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.

Authors:  Masaya Akashi; Satoshi Wanifuchi; Eiji Iwata; Daisuke Takeda; Junya Kusumoto; Shungo Furudoi; Takahide Komori
Journal:  Oral Maxillofac Surg       Date:  2017-12-09

3.  Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study.

Authors:  Suad Aljohani; Riham Fliefel; Teresa Franziska Brunner; Aristeidis Chronopoulos; Nada Binmadi; Sven Otto
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

4.  Three-Dimensional Evaluation of Isodose Radiation Volumes in Cases of Severe Mandibular Osteoradionecrosis for the Prediction of Recurrence after Segmental Resection.

Authors:  Haye H Glas; Joep Kraeima; Silke Tribius; Frank K J Leusink; Carsten Rendenbach; Max Heiland; Carmen Stromberger; Ashkan Rashad; Clifton D Fuller; Abdallah S R Mohamed; Stephen Y Lai; Max J H Witjes
Journal:  J Pers Med       Date:  2022-05-20

5.  Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.

Authors:  Takuma Watanabe; Keita Asai; Shizuko Fukuhara; Ryuji Uozumi; Kazuhisa Bessho
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

6.  Antibiotic therapy for the prevention of osteoradionecrosis following tooth extraction in head-and-neck cancer patients postradiotherapy: An 11-year retrospective study.

Authors:  Luiz Felipe Palma; Marcelo Marcucci; Cíntia Maria Remondes; Leandro Chambrone
Journal:  Natl J Maxillofac Surg       Date:  2021-12-13

Review 7.  Clinical impact of bisphosphonates in root canal therapy.

Authors:  Mothanna K AlRahabi; Hani M Ghabbani
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.